Stock screenerAll disclosures →
EDGAR →
CBIO
Conviction 65HealthcareScan · Mon, Aug 10, 2026CBIO$17.33+2.91%
ResistanceSupportVol 14Vol MA14 373.57K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price17.33
Change+2.91%
Gap+1.04%
Rel volume4.11×
Avg volume484.05K
Avg $ vol7.74M
SMA 2015.85
SMA 5016.97
SMA 20015.01
Price vs 50+2.11%
Price vs 200+15.48%
MA stackbullish
50/200 cross—
Supertrenddown · 18.64
RSI (14)56
MACD hist0.25
MACD crossbull · 4d
Stoch %K / %D88 / 76
ADX (14)15
+DI / −DI25 / 15
RSI divergenceBullish
MACD divergenceBullish
ATR %+7.37%
ADR %8.07%
52w high26.98
52w low8.94
From 52w high-35.77%
Above 52w low+93.85%
New 52w highNo
SqueezeFired
Bollinger width21.84%
%B0.93
Donchian pos87.66%
Donchian high17.80
Donchian low13.99
AVWAP (52w high)18.05
vs AVWAP high-4.01%
AVWAP (52w low)17.02
vs AVWAP low+1.84%
OBV trendUp
Chaikin MF (20)0.03
Today vs 20d4.11×
Avg vol (14d)373.57K
Avg vol (20d)484.05K
Avg $ vol (20d)7.74M
Market cap643.7M
RS 3m (vs SPY)-12.14%
RS 6m (vs SPY)+64.84%
RS line new highNo
Trend template6/8
Technical rank81.3
1 week+16.54%
1 month-0.06%
3 months-7.62%
6 months+82.23%
1 year+57.55%
YTD+56.41%
P/E-4.18
P/B3.94
P/S59.36
P/FCF-8.88
EPS-0.5900
Div yield—
ROE-94.30%
ROA-84.23%
Debt/Eq—
Current9.66
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth-306.40%
Price target29.50
Target upside70.23%
Analyst ratingBuy
Institutional76.19%
Ent. value472.11M
Revenue0
Net income-24.84M
Gross profit—
Free cash flow-72.45M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out—
Employees44
ListedMon, Jun 16, 2025
Free float18.11M
Float %65.7%
Short interest3.74M
Days to cover9.7d
Short volume38.1%
Squeeze score80 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.74 vs −$0.78
Last surprise+5.1% beat
Setup gradeB
Conviction65 / 100
Pattern quality—
Tech rank81.3 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance19.03
Support14.23
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in CBIO
No recent disclosed trades by Congress in CBIO. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in CBIO · 8 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Violin Jonathan Director · Stock Option (Right to Buy) · 2026-06-02 | Grant | 11.05K | $0 | 2026-06-02 | 2026-06-03 |
Moran Susan Director · Stock Option (Right to Buy) · 2026-06-02 | Grant | 11.05K | $0 | 2026-06-02 | 2026-06-03 |
Fairmount Healthcare Fund II L.P. Director · Stock Option (Right to Buy) · 2026-06-02 | Grant | 11.05K | $0 | 2026-06-02 | 2026-06-03 |
Fairmount Funds Management LLC Director · Stock Option (Right to Buy) · 2026-06-02 | Grant | 11.05K | $0 | 2026-06-02 | 2026-06-03 |
Lubner David Charles Director · Stock Option (Right to Buy) · 2026-06-02 | Grant | 11.05K | $0 | 2026-06-02 | 2026-06-03 |
Harwin Peter Evan Director · Stock Option (Right to Buy) · 2026-06-02 | Grant | 11.05K | $0 | 2026-06-02 | 2026-06-03 |
Kiselak Tomas Director · Stock Option (Right to Buy) · 2026-06-02 | Grant | 11.05K | $0 | 2026-06-02 | 2026-06-03 |
Balcom Alexandra Director · Stock Option (Right to Buy) · 2026-06-02 | Grant | 11.05K | $0 | 2026-06-02 | 2026-06-03 |
SEC filings
EDGAR filings in CBIO · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.